BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, February 3, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Oct. 23, 1995
View Archived Issues
FDA OKS ROCHE'S ROFERAN-A FOR CHRONIC MYELOGENOUS LEUKEMIA
Read More
OTHER NEWS TO NOTE
Read More
CORRECTION
Read More
MANAGED CARE FIRMS WANT CONTROL OF DRUG COST EFFECTIVENESS STUDIES
Read More
ENZON'S DISMUTEC FAILS TO SHOW STATISTICAL SIGNIFICANCE
Read More
BACTERIAL ANTIGEN-CODING REGION IMMUNIZES MICE; HIV UP NEXT
Read More
BIOGEN BEATS PROJECTIONS WITH PER-SHARE INCOME OF 3 CENTS
Read More
NEUPOGEN FAILS TO MEET PRIMARY ENDPOINT EPOGEN SALES HELP DRIVE
Read More